Back to NYSDA Blog

You are here

October 11, 2017

FDA Issues Update on Efforts to Engage Patients in Regulatory Approval Processes

The United States Food and Drug Administration (FDA) has issued an update on its efforts to engage patients in its regulatory approval processes.  The FDA believes that involving the end-user – the patient – in identifying health priorities and outcomes desired from health interventions is critically important.  This requires cultures and processes that ensure routine integration of these patient perspectives at each key stage of product development.  To read the FDA update on its efforts to engage patients in its regulatory approval processes, use the link below.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm579842.htm

All Blog Posts >

NYSDA Blog posts

AHRQ Issues Regulatory Activities Update
The Agency for Healthcare Research and Quality (AHRQ) has issued its weekly update on its major regu.
NYSDOH Issues Whiteboard Video on Medicaid DSRIP Best Practices
The New York State Department of Health (NYSDOH) has issued the latest installment in its&.
ONC Issues HIT Regulatory Update
The Office of the National Coordinator for Health Information Technology (ONC) has issued its weekly.